Edition:
United States

Harbin Pharmaceutical Group Co Ltd (600664.SS)

600664.SS on Shanghai Stock Exchange

3.85CNY
14 Dec 2018
Change (% chg)

¥0.09 (+2.39%)
Prev Close
¥3.76
Open
¥3.75
Day's High
¥3.88
Day's Low
¥3.74
Volume
22,870,636
Avg. Vol
9,295,850
52-wk High
¥6.00
52-wk Low
¥3.27

Latest Key Developments (Source: Significant Developments)

Owner Of Harbin Pharma's Controlling Shareholder Set To Change To Citic Capital
Friday, 23 Feb 2018 09:51am EST 

Feb 23 (Reuters) - Harbin Pharmaceutical Group Co Ltd <600664.SS>::SAYS CONTROLLING SHAREHOLDER'S OWNER SET TO CHANGE TO CITIC CAPITAL FROM HARBIN STATE ASSET REGULATOR AFTER CAPITAL BOOST.SAYS CITIC CAPITAL WILL OWN 60.9 PERCENT STAKE IN ITS CONTROLLING SHAREHOLDER, HARBIN STATE ASSET REGULATOR'S STAKE WILL BE REDUCED TO 32.0 PERCENT.  Full Article

Harbin Pharma Scraps Plan For Unit To Bid For GNC's China Business
Wednesday, 14 Feb 2018 04:09am EST 

Feb 14 (Reuters) - Harbin Pharmaceutical Group Co Ltd <600664.SS>::SAYS CONTROLLING SHAREHOLDER SIGNS AGREEMENT TO BUY GNC HOLDINGS' <<>> CONVERTIBLE PREFERENCE SHARES WORTH $299.95 MILLION.SAYS IT SCRAPS PLAN FOR UNIT HPGC RENMINTONGTAI PHARMA TO BID GNC'S CHINA BUSINESS.  Full Article

GNC And Harbin Pharmaceutical Announce $300 Mln Strategic Investment
Tuesday, 13 Feb 2018 06:00am EST 

Feb 13 (Reuters) - Harbin Pharmaceutical Group Co Ltd <600664.SS>::GNC AND HARBIN PHARMACEUTICAL ANNOUNCE $300 MILLION STRATEGIC INVESTMENT AND CHINA JOINT VENTURE.GNC HOLDINGS INC - ‍ALSO ANNOUNCED PLANS TO AMEND CERTAIN TERMS AND EXTEND MATURITY DATE OF ITS EXISTING TERM LOAN FACILITY DUE MARCH 2019​.GNC HOLDINGS INC - ‍COMPANY IS SEEKING TO EXTEND MATURITY DATE OF FACILITY BY TWO YEARS, TO MARCH 2021​.GNC HOLDINGS INC - ‍UPON EFFECTIVENESS OF AMENDMENT, MATURITY DATE OF TERM LOANS HELD BY LENDERS CONSENTING TO AMENDMENT WILL BE EXTENDED BY TWO YEARS​.GNC HOLDINGS -‍UPON EFFECTIVENESS OF AMENDMENT, CO'S EXISTING REVOLVING CREDIT FACILITY WILL BE CANCELLED, GNC WILL ENTER INTO NEW $100 MILLION ABL REVOLVER​.GNC HOLDINGS INC - ‍COMPANY WILL ALSO ISSUE A $275 MILLION ABL TERM LOAN AS PART OF MATURITY EXTENSION​.GNC HOLDINGS- REACHED AGREEMENT REGARDING STRATEGIC PARTNERSHIP AND CHINA JOINT VENTURE AGREEMENT WITH HARBIN PHARMACEUTICAL GROUP HOLDING CO., LTD​.GNC HOLDINGS INC - ‍UNDER TERMS OF AGREEMENT HAYAO WILL INVEST APPROXIMATELY $300 MILLION IN GNC, BECOMING SINGLE LARGEST SHAREHOLDER IN GNC​.GNC HOLDINGS - ‍IN CONNECTION WITH INVESTMENT, GNC BOARD TO BE EXPANDED TO 11 MEMBERS INCLUDING 5 MEMBERS FROM GNC, 5 MEMBERS FROM HAYAO,KEN MARTINDALE​.GNC HOLDINGS - ‍IN ADDITION, GNC,HAYAO HAVE AGREED TO FORM JOINT VENTURE FOR MANUFACTURING, MARKETING, SALE, DISTRIBUTION OF GNC-BRANDED PRODUCTS IN CHINA​.  Full Article

Harbin Pharmaceutical's 2017 Net Profit Down 48.4 Percent Y/Y At 407.0 Million Yuan
Friday, 9 Feb 2018 06:45am EST 

Feb 9 (Reuters) - Harbin Pharmaceutical Group Co Ltd <600664.SS>::SAYS 2017 NET PROFIT DOWN 48.4 PERCENT Y/Y AT 407.0 MILLION YUAN ($64.64 million).  Full Article

Harbin Pharmaceutical Expects 2017 Net Profit To Fall 46-51 Percent Y/Y
Tuesday, 30 Jan 2018 04:16am EST 

Jan 30 (Reuters) - Harbin Pharmaceutical Group Co Ltd <600664.SS>::SAYS IT EXPECTS 2017 NET PROFIT TO FALL 46-51 PERCENT Y/Y VERSUS 788.1 MILLION YUAN ($124.40 million) YEAR AGO.  Full Article

Harbin Pharmaceutical's 9-month net profit down 56.8 pct y/y
Thursday, 26 Oct 2017 07:33am EDT 

Oct 26 (Reuters) - Harbin Pharmaceutical Group Co Ltd <600664.SS>:Says 9-month net profit down 56.8 percent y/y.  Full Article

HPGC Renmintongtai Pharmaceutical and partner jointly set up pharmaceutical firm
Friday, 11 Aug 2017 05:44am EDT 

Aug 11(Reuters) - HPGC Renmintongtai Pharmaceutical Corp <600829.SS>:Says it and Harbin Pharmaceutical Group Co Ltd <<<600664.SS>>> jointly set up a Harbin-based pharmaceutical firm, with registered capital of 50 million yuan .Says the company holds a 99 percent stake in the pharmaceutical firm.  Full Article

Harbin Pharmaceutical Group's H1 net profit down 8.2 pct y/y
Wednesday, 9 Aug 2017 07:05am EDT 

Aug 9 (Reuters) - Harbin Pharmaceutical Group Co Ltd <600664.SS>:Says H1 net profit down 8.2 percent y/y at 347.6 million yuan ($52.07 million).  Full Article

Harbin Pharma's 2016 net profit rises 35.9 percent y/y
Friday, 3 Mar 2017 04:25am EST 

Harbin Pharmaceutical Group Co Ltd <600664.SS> :Says 2016 net profit up 35.9 percent y/y at 788.1 million yuan ($114.27 million).  Full Article

HPGC Renmintongtai Pharmaceutical sees FY2016 net profit to up by 45 pct to 65 pct
Thursday, 26 Jan 2017 02:43am EST 

HPGC Renmintongtai Pharmaceutical Corp <600829.SS> : Sees net profit for FY2016 to increase by 45 percent to 65 percent, compared to net profit of FY2015 (138.9 million yuan) .Says large growth in core businesses and relocation compensation received in unit as main reasons for the forecast.  Full Article

REFILE-BRIEF-Harbin Pharmaceutical Signs Agreement With Israel's Teva Pharmaceutical Industries

* SAYS IT SIGNS AUTHORIZATION AND DISTRIBUTION AGREEMENT WITH ISRAEL'S TEVA PHARMACEUTICAL INDUSTRIES, EXPECTS INVESTMENT OF ABOUT 160 MILLION YUAN Source text in Chinese: https://bit.ly/2PdGwJL Further company coverage: (Reporting by Hong Kong newsroom)